These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 11170862)
21. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection? Nittis T; Guittat L; Stewart SA Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854 [TBL] [Abstract][Full Text] [Related]
22. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183 [TBL] [Abstract][Full Text] [Related]
23. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss. Arkus N J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310 [TBL] [Abstract][Full Text] [Related]
24. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Klingelhutz AJ Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595 [TBL] [Abstract][Full Text] [Related]
25. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646 [TBL] [Abstract][Full Text] [Related]
26. Immortalized cells with no detectable telomerase activity. A review. Reddel RR; Bryan TM; Murnane JP Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849 [TBL] [Abstract][Full Text] [Related]
27. Telomerase in human development and cancer. Shay JW J Cell Physiol; 1997 Nov; 173(2):266-70. PubMed ID: 9365534 [TBL] [Abstract][Full Text] [Related]
28. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Healy KC Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645 [TBL] [Abstract][Full Text] [Related]
29. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Hackett JA; Greider CW Oncogene; 2002 Jan; 21(4):619-26. PubMed ID: 11850787 [TBL] [Abstract][Full Text] [Related]
30. Multiple pathways for the regulation of telomerase activity. Holt SE; Wright WE; Shay JW Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114 [TBL] [Abstract][Full Text] [Related]
37. Replication and/or separation of some human telomeres is delayed beyond S-phase in pre-senescent cells. Ofir R; Yalon-Hacohen M; Segev Y; Schultz A; Skorecki KL; Selig S Chromosoma; 2002 Sep; 111(3):147-55. PubMed ID: 12355203 [TBL] [Abstract][Full Text] [Related]
38. Extensive allelic variation and ultrashort telomeres in senescent human cells. Baird DM; Rowson J; Wynford-Thomas D; Kipling D Nat Genet; 2003 Feb; 33(2):203-7. PubMed ID: 12539050 [TBL] [Abstract][Full Text] [Related]
39. Stochastic mechanism of cellular aging--abrupt telomere shortening as a model for stochastic nature of cellular aging. Rubelj I; Vondracek Z J Theor Biol; 1999 Apr; 197(4):425-38. PubMed ID: 10196087 [TBL] [Abstract][Full Text] [Related]
40. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Russo I; Silver AR; Cuthbert AP; Griffin DK; Trott DA; Newbold RF Oncogene; 1998 Dec; 17(26):3417-26. PubMed ID: 10030665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]